CompletedNot Applicable

Mineral and Bone Disorders Outcomes in Stage 5D of Chronic Kidney Disease

Japan8,020 participantsStarted 2008-01

Plain-language summary

The MBD-5D is a prospective observational study with a case-cohort and a cohort design. Eligible patients are receiving hemodialysis and have secondary hyperparathyroidism. The study's three goals are (1) to record the patients' characteristics, and variation in the patterns of their treatment; (2) to analyze factors associated with variation in those medical practice patterns; and (3) to identify practice patterns and other factors that affect hospitalization, mortality, and other patient-level outcomes.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * patients receiving hemodialysis * patients whose intact PTH concentration is at least 180 pg/mL (106 pg/mL for whole PTH) OR patients who are receiving intravenous active vitamin D sterols or oral active vitamin D sterols (falecalcitriol) Exclusion Criteria: * patients have been undergoing hemodialysis for less than 3 months

What they're measuring

all-cause mortality

Timeframe: 3 years

cardiovascular mortality

Timeframe: 3 years

hospitalization

Timeframe: 3 years

Trial details

NCT IDNCT00995163

SponsorKyowa Kirin Co., Ltd.

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2011-01

View on ClinicalTrials.gov More End Stage Renal Disease trials